Cargando…

Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis: A Decision Tree Analysis by Indication

INTRODUCTION: Treatment persistence is a proxy for efficacy, safety and patient satisfaction, and a switch in treatment or treatment discontinuation has been associated with increased indirect and direct costs in inflammatory arthritis (IA). Hence, there are both clinical and economic incentives for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dalén, Johan, Svedbom, Axel, Hernlund, Emma, Olofsson, Tor, Black, Christopher M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499966/ https://www.ncbi.nlm.nih.gov/pubmed/37599341 http://dx.doi.org/10.1007/s12325-023-02600-3

Ejemplares similares

Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational Study
por: Dalén, Johan, et al.
Publicado: (2021)

Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line
por: Svedbom, Axel, et al.
Publicado: (2017)

Healthcare-Related Costs Associated with Switching Subcutaneous Tumor Necrosis Factor-α Inhibitor in the Treatment of Inflammatory Arthritis: a Retrospective Study
por: Dalén, Johan, et al.
Publicado: (2020)

Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis – A Systematic Literature Review
por: Luttropp, Karin, et al.
Publicado: (2020)

Persistence with golimumab in immune-mediated rheumatic diseases: a systematic review of real-world evidence in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis
por: Svedbom, Axel, et al.
Publicado: (2017)

Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis
por: Takacs, Peter, et al.
Publicado: (2019)

Impact of extra-articular spondyloarthritis manifestations and comorbidities on drug retention of a first TNF-inhibitor in ankylosing spondylitis: a population-based nationwide study
por: Lindström, Ulf, et al.
Publicado: (2018)

Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD)
por: Acar, Mustafa, et al.
Publicado: (2018)

Predictors of unacceptable pain with and without low inflammation over 5 years in early rheumatoid arthritis—an inception cohort study
por: Eberhard, Anna, et al.
Publicado: (2021)

Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study
por: Lindström, Ulf, et al.
Publicado: (2023)

Identifying relapse predictors in individual participant data with decision trees
por: Böttcher, Lucas, et al.
Publicado: (2023)

Decision tree analysis for evaluating disease activity in patients with rheumatoid arthritis
por: Wang, Lei, et al.
Publicado: (2021)

Comparative Persistence of the TNF Antagonists in Rheumatoid Arthritis – A Population-Based Cohort Study
por: Fisher, Anat, et al.
Publicado: (2014)

Biologic TNF inhibiting agents for treatment of rheumatoid arthritis: persistence and dosing patterns in Germany
por: Neubauer, Sarah, et al.
Publicado: (2014)

Interleukin-17 and - 23 Inhibitors Associated with Direct Effects on Depressive Symptoms in Psoriasis: A Register Study
por: SVEDBOM, Axel, et al.
Publicado: (2023)

Predictors of response to TNF inhibitors in rheumatoid arthritis: an individual patient data pooled analysis of randomised controlled trials
por: Law-Wan, Johan, et al.
Publicado: (2021)

Posttraumatic Stress Disorder, Depression, Anxiety, and Persistence of Methotrexate and TNF Inhibitors in Patients with Rheumatoid Arthritis
por: Desilet, Luke W., et al.
Publicado: (2020)

Adherence and persistence of subcutaneous biologics delivered through homecare services to a cohort of patients with rheumatoid arthritis
por: Alvarez-Madrazo, Samantha, et al.
Publicado: (2017)

Health behaviours as predictors of the Mediterranean diet adherence: a decision tree approach
por: Bôto, Joana Margarida, et al.
Publicado: (2022)

Osteoporosis in the European Union: medical management, epidemiology and economic burden: A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)
por: Hernlund, E., et al.
Publicado: (2013)

Osteoporosis in the European Union: a compendium of country-specific reports
por: Svedbom, A., et al.
Publicado: (2013)

Risk of respiratory infection in patients with plaque psoriasis
por: Svedbom, Axel, et al.
Publicado: (2021)

Serum adiponectin as a predictor of laboratory response to anti-TNF-α therapy in rheumatoid arthritis
por: Sikorska, Dorota, et al.
Publicado: (2018)

Dose REduction strategy of subcutaneous TNF inhibitors in rheumatoid arthritis: design of a pragmatic randomised non inferiority trial, the DRESS study
por: den Broeder, Alfons A, et al.
Publicado: (2013)

Recruitment decision Tree
por: Marcastel, Fabienne
Publicado: (2016)

Subcutaneous abatacept for the treatment of rheumatoid arthritis
por: Schiff, Michael
Publicado: (2013)

Predictors and patterns of problematic Internet game use using a decision tree model
por: Rho, Mi Jung, et al.
Publicado: (2016)

Predictors of intentional intoxication using decision tree modeling analysis: a retrospective study
por: Oh, Eun Seok, et al.
Publicado: (2018)

Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists
por: Finckh, Axel, et al.
Publicado: (2012)

Relationship between beliefs about medicines, adherence to treatment, and disease activity in patients with rheumatoid arthritis under subcutaneous anti-TNFα therapy
por: Horne, Rob, et al.
Publicado: (2018)

The clinical decision analysis using decision tree
por: Bae, Jong-Myon
Publicado: (2014)

Building more accurate decision trees with the additive tree
por: Luna, José Marcio, et al.
Publicado: (2019)

Predictors of response to TNF antagonists in patients with ankylosing spondylitis and psoriatic arthritis: systematic review and meta-analysis
por: Maneiro, Jose Ramon, et al.
Publicado: (2015)

Update on subcutaneous methotrexate for inflammatory arthritis and psoriasis
por: Vena, Gino Antonio, et al.
Publicado: (2018)

A Decision Tree Lifted Domain for Analyzing Program Families with Numerical Features
por: Dimovski, Aleksandar S., et al.
Publicado: (2021)

Diagnostic decision tree in dementia
por: Wetherell, Julie Loebach, et al.
Publicado: (2003)

Decision trees in epidemiological research
por: Venkatasubramaniam, Ashwini, et al.
Publicado: (2017)

On the Depth of Decision Trees with Hypotheses
por: Moshkov, Mikhail
Publicado: (2022)

Prevalence and Persistence of Misconceptions in Tree Thinking
por: Kummer, Tyler A., et al.
Publicado: (2016)

Cost comparison of MRSA screening and management – a decision tree analysis
por: Tübbicke, Andrea, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_p2tlnsksus4gij4a9gd4htarqd